With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...

Ori Biotech's IRO platform has achieved an Advanced Manufacturing Technology designation from the FDA. The honor is extended to companies that show their technology can cut development timelines or ...

A roundtable discussion reveals how hybrid distributed models could provide a bridge from centralized cell-therapy ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

Automation, decentralized manufacturing, and supportive regulations are helping to surmount technical difficulties in cell and gene therapy manufacturing.

The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...